3 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 3 of 3 clinical reviews.
Evidence review of bremelanotide (Vyleesi) efficacy differences in Hispanic / Latino populations, covering RECONNECT trial subgroup data, MC4R pharmacogenomics, metabolic confounders, and practical dosing guidance.
Evidence-based review of bremelanotide (Vyleesi) efficacy in South Asian women, including MC4R pharmacogenomics, cardiovascular screening at lower BMI thresholds, and ethnicity-stratified trial gaps.
Evidence-based review of how bremelanotide (Vyleesi) safety, pharmacogenomics, and dosing considerations differ for South Asian women, including cardiovascular monitoring and melanocortin receptor variability.